Lv51
1070 积分 2020-04-04 加入
A validated bioanalytical LC-MS/MS method for the simultaneous determination of molnupiravir, N-hydroxycytidine, and baricitinib in human plasma
2小时前
求助中
A DAR sensitive hybrid LBA-LC-MS/MS assay for quantitation of conjugated payload from a non-cleavable ADC in human serum
2小时前
待确认
Consideration for immunogenicity assay development for oligonucleotide therapeutics
1个月前
已完结
Drawing a line in the sand: impact of analytical choices on anti-drug antibody cut-points and testing outcomes
1个月前
已完结
Calculating Receptor Occupancy using TMDD Models – What has to be Considered?
1个月前
已完结
Drawing a line in the sand: impact of analytical choices on anti-drug antibody cut-points and testing outcomes
1个月前
已完结
Pharmaceutical drug monitoring: the role of oral fluid sampling
2个月前
已关闭
Advances in the use of DNA aptamers for bioanalysis of antibody-based therapeutics
2个月前
已关闭
Preclinical pharmacokinetics of novel MYDGF for human PK and dose prediction
2个月前
已关闭
Validation approach of an LC-MS/MS assay for ADA detection, applied to a Von Willebrand factor-targeted biotherapeutic
3个月前
已完结
皖公网安备34019202002308
